 VolitionRx NYSE-A:VNRX Limited said it will work with a renowned French veterinary referral clinic to further assess the potential of its cancer screening technology in dogs and cats. A non-interventional study of Volitions Nu.Q Vet Cancer Test will be overseen by Dr Jérôme Benoit, the clinical director of Oncovet in Lille. 